Breast Cancer
Conditions
Interventions
“Sigen Tea” Group:Sigen Tea and health education
Sponsors
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1.Female, age18-70 years old; 2.Post-operative breast cancer and histopathological findings confirming a malignant breast tumor; 3.No change in breast cancer-related treatment regimen is expected during the conduct of this study (e.g., patients are on chemotherapy from enrollment to the end of the intervention); 4.The diagnostic criteria for mild abnormalities of lipids were met after fasting blood sampling. 5.If previous treatment with lipid-lowering drugs is discontinued for more than two weeks; 6.Informed consent was signed by patients who understood and agreed to participate in this study.
Exclusion criteria
Exclusion criteria: 1.Those with severe circulatory, respiratory, digestive, hematological, urinary, neurological, and endocrine system diseases, such as acute myocardial infarction, cardiac failure, renal insufficiency, acute cerebral infarction, and lupus erythematosus. The researcher believes that the patient's other system diseases will affect the results of this study; 2.Those with diseases that affect lipid metabolism, such as thyroid disease, gout, diabetes, etc; 3.Those who have taken drugs that affect lipid metabolism such as beta-blockers, adrenocorticosteroids, thiazide diuretics, statins, betablockers, etc. in the last two weeks; 4.Those who have taken other Chinese traditional medicines regularly in the last two weeks; 5.Those with distant metastases of breast cancer; 6.Those with other malignant tumor; 7.Those with familial hereditary hyperlipidemia; 8.Those allergic to the composition of "Sigen Tea", including Rhodiola crenulata, Curcumae rhizoma, Rhizoma polygonati and Radix actinidiae; 9.Those unable to cooperate due to psychiatric disorders, lalopathy or other reasons; or refuse to have their draw blood; 10.Those who have participated in other clinical trials within the last two weeks or during the same period 11.Those who are pregnant or lactating.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The total effective rate in the evaluation criteria for improving blood lipids?; | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes of blood lipid level;Changes of inflammatory level;Body mass index;Body fat;Body fat percentage;Waist-to-hip ratio;Subcutaneous fat rate;Visceral fat index; | — |
Countries
China
Contacts
Public ContactMinjia Yuan
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Outcome results
None listed